Systems engineering×Computational biology

Systems engineering has spent a decade proving that complex, coupled systems—from climate to manufacturing—can be made simulatable, predictable, and lifecycle-manageable through digital twin and model-based frameworks. Computational biology now possesses the richest machine-readable substrate in its history: proteome-scale structures from AlphaFold, genome-wide interaction networks from STRING, and phylogenomic trees at scale. The missing step is the formalism to fuse these biological data layers into coherent, executable system models—exactly what systems engineering exists to provide. This collision will produce the first generation of rigorous biological digital twins: cellular, disease-state, and organism-level models that update from experimental data and support design-of-experiment in the same way CMIP6 couples atmospheric and oceanic subsystems.

Three structural signals converge simultaneously. First, biochemical engineering already sits at the bridge, meaning the vocabulary of mass-balance, process control, and system state is already shared. Second, 25 authors are already publishing independently in both fields—this is a pre-fusion talent pool waiting for a framing problem to coalesce around. Third, field momentum is asymmetric in a productive way: computational biology is high-volume and data-rich (1,527 works, AlphaFold at 46K cites) but methods-constrained; systems engineering is lower-volume but methods-dense, with digital twin and model-based systems engineering (MBSE) frameworks proven at scale. The commercialization bridge field signals that industrial actors are already probing the connection, even without formal academic co-publication.

Groups with simultaneous competency in model-based systems engineering and quantitative systems pharmacology or systems biology will move fastest. National laboratories that run both large-scale simulation infrastructure and genomics pipelines (DOE-funded sites in particular) have the compute and cross-disciplinary staff. Pharma computational science departments that have absorbed MBSE language through regulatory biosimulation (population PK/PD, physiologically-based models) are the closest industrial analog. Synthetic biology organizations that already frame cell engineering as a code-compile-debug loop have the philosophical foundation and will be early adopters of formal SE toolchains applied to biological system models.

A model intercomparison project for cellular systems—analogous in structure to CMIP6—where a defined set of canonical biological subsystems (e.g., the DNA-damage response pathway, a core metabolic network) is represented by competing coupled computational models from different formalisms (ODE-based systems biology, agent-based, digital-twin state-machine). Fund a 3-year benchmarking consortium that establishes shared interface standards, validation datasets from perturbation experiments, and uncertainty-quantification protocols. The deliverable is a reusable MBSE ontology and model-exchange format for biological systems that lets AlphaFold structure outputs and STRING interaction data plug directly into systems-engineering simulation environments.